All stocks Β· ROOPAIND
RI

Roopa Industries Ltd.

ROOPAIND BSE Chemicals Basic Materials

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenyl phosphine, abacavir sulphate, d-penicillamine, s-octaba…

ISIN INE443C01010
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenyl phosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap39 Cr
P/E9.14
Div Yield0.00 %
Book Valueβ‚Ή22.40
52w Highβ‚Ή63.40
52w Lowβ‚Ή38.10
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 33.32 30.14 33.54 28.74 35.07 29.83 30.73 25.61 34.51 22.08 19.24 14.15 14.95
Expenses 31.79 27.07 31.50 27.11 33.67 29.39 29.76 23.97 33.46 21.15 18.36 12.45 13.92
Operating Profit 1.53 3.07 2.04 1.63 1.40 0.44 0.97 1.64 1.05 0.93 0.88 1.70 1.03
OPM % 4.59 10.19 6.08 5.67 3.99 1.48 3.16 6.40 3.04 4.21 4.57 12.01 6.89
Other Income 0.02 -3.98 0.00 0.00 0.02 1.14 0.92 0.00 0.24 0.71 0.40 0.02 0.00
Depreciation 0.19 0.21 0.19 0.19 0.20 0.19 0.26 0.20 0.20 0.19 0.23 0.23 0.23
Interest 0.93 0.74 0.79 0.83 0.86 0.66 0.67 0.71 0.79 0.68 0.70 0.69 0.56
Profit before tax 0.43 -1.86 1.06 0.61 0.36 0.73 0.96 0.73 0.30 0.77 0.35 0.80 0.24
Tax % 23.26 -23.12 26.42 24.59 25.00 43.84 20.83 19.18 10.00 38.96 25.71 25.00 20.83
Net Profit 0.33 -1.43 0.77 0.46 0.28 0.42 0.76 0.58 0.27 0.46 0.27 0.60 0.19
EPS in Rs 0.42 -1.82 0.98 0.58 0.36 0.53 0.97 0.74 0.34 0.58 0.34 0.76 0.24

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 128.00121.0070.0076.0051.0029.0028.0030.0019.0030.0031.0031.00
Expenses 119.00117.0066.0072.0048.0026.0026.0028.0022.0028.0031.0029.00
Operating Profit 8.004.004.004.003.003.002.002.00-3.002.00-1.002.00
OPM % 6.003.406.005.007.0010.007.008.00-14.007.00-2.807.00
Other Income -4.002.001.001.000.000.001.000.005.000.003.000.00
Interest 3.003.003.002.001.001.001.001.001.002.001.001.00
Depreciation 1.001.001.001.001.001.001.001.001.001.001.001.00
Profit before tax 0.003.002.002.001.001.001.001.000.000.000.000.00
Tax % 56.0025.0030.0025.0026.0024.0054.0024.00-22.0056.0035.0011.00
Net Profit 0.002.002.001.001.001.000.001.001.000.000.000.00
EPS in Rs 0.102.581.931.721.300.920.470.760.690.240.220.20
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 8.008.008.008.008.008.008.008.008.008.008.008.00
Reserves 10.0010.008.006.005.004.003.003.002.002.001.001.00
Borrowings 31.0033.0026.0019.0012.0013.0014.0015.0016.0011.008.008.00
Other Liabilities 23.0026.0023.0024.0024.0021.0014.0011.0010.008.008.008.00
Total Liabilities 72.0076.0065.0057.0049.0046.0038.0036.0035.0029.0025.0026.00
Fixed Assets 8.008.009.0010.0010.0010.0011.006.006.007.007.008.00
CWIP 0.001.001.001.001.000.000.004.002.000.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 64.0068.0055.0046.0039.0036.0028.0026.0027.0022.0018.0018.00
Total Assets 72.0076.0065.0057.0049.0046.0038.0036.0035.0029.0025.0026.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 5.00-7.002.000.002.00-1.002.004.00-5.00-1.001.001.00
Cash from Investing Activity 0.002.001.00-1.004.001.001.00-2.002.000.000.000.00
Cash from Financing Activity -8.005.00-2.002.00-5.00-1.00-3.00-2.002.002.00-1.000.00
Net Cash Flow -3.000.001.000.001.000.000.000.000.000.000.000.00
Free Cash Flow 4.00-7.002.00-2.002.00-1.002.002.00-7.00-2.001.000.00
CFO/OP % 58.00-144.0060.002.0078.00-11.00157.00184.00168.00-50.00-146.0028.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 63.0039.0043.0034.00112.00147.00157.00134.00233.00146.0099.0066.00
Inventory Days 102.00121.00168.00109.00140.00409.00256.00171.00217.00139.0070.00143.00
Days Payable 41.0056.0096.0042.0086.00280.00219.00123.00177.00122.00100.00132.00
Cash Conversion Cycle 123.00104.00116.00101.00166.00277.00194.00182.00273.00164.0069.0077.00
Working Capital Days 32.0036.0010.001.0037.00114.00104.00108.00214.00114.0069.0032.00
ROCE % 15.0012.0012.0013.0010.008.009.009.006.0010.0010.0010.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03 48.03
FIIs 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25
Public 51.72 51.72 51.71 51.72 51.71 51.71 51.71 51.72 51.72 51.73 51.72 51.72
No. of Shareholders 3,888 3,954 3,952 3,982 4,002 4,007 4,005 3,813 3,616 3,622 3,584 3,490

Corporate Actions

No corporate actions recorded.

Announcements

5 filings